Hans Jorgen Petersen

Title: Innovations by Hans Jorgen Petersen

Introduction

Hans Jorgen Petersen is a notable inventor based in Herlev, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications. With a total of 2 patents, his work has the potential to impact medical practices significantly.

Latest Patents

Petersen's latest patents include innovative compounds aimed at treating hypertension. One of his notable inventions is the antihypertensive pyridylguanidine compounds. This invention relates to a series of new compounds that are useful in both human and veterinary medical practices. The compounds have shown to be highly potent hypotensive agents, providing a pronounced reduction in blood pressure while maintaining low toxicity and a high therapeutic ratio. Another significant patent is the crystalline pivaloyloxymethyl D(-)-α-aminobenzylpenicillinate. This compound is presented in a novel crystalline form that is stable, readily absorbable, and has no bitter taste, making it a valuable addition to pharmaceutical preparations.

Career Highlights

Throughout his career, Hans Jorgen Petersen has worked with reputable companies, including Leo Pharmaceutical Products Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and the development of new therapeutic compounds.

Collaborations

Petersen has collaborated with notable colleagues such as Ernst T Binderup and Sven Liisberg. These collaborations have likely enriched his research and development efforts, leading to the successful creation of his patented compounds.

Conclusion

Hans Jorgen Petersen's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work continues to hold promise for improving treatment options in healthcare.